These results demonstrated that HK2 could elevate Akt1 and p-Akt1 expression in human ovarian cancer cells, subsequently enhancing cell motility by inducing Fibronectin and MMP9 expression, promoting cell growth by reducing p21 and p27 expression. Here, MMP9 is linked to ovarian cancer.